The global scaffold technology market was valued at US$ 2.05 billion in 2023 and is expected to reach US$ 8.58 billion by 2034, growing at a compound annual growth rate (CAGR) of 13.9% between 2024 and 2034.
| Company Name | CytoNest Inc. |
| Headquarters | Maryland, U.S., North America |
| Recent Development | In August 2024, an innovative fiber scaffold that enhances tissue engineering and cell production was the first commercial product of the University of Georgia firm CytoNest Inc., which debuted last month. The device, known as the CytoSurge 3D fiber scaffold, has uses in the generation of cultured meat and seafood, biopharmaceuticals, cell therapies, and cell research. |
| Company Name | Tempo Therapeutics |
| Headquarters | California, U.S., North America |
| Recent Development | In September 2024, the first human study for Tempo Therapeutics' tissue regeneration product, TT101, began with patients who have had surgical resection. An integrative scaffold with the ability to regenerate soft tissue is called TT101. The clinical trial is being funded by proceeds from a $12 million Series A investment transaction that was obtained in March. |
| Product Description | Country | Quantity | Consignee Name | Shipper Name |
| PLASTIC PARTS FOR THE MANUFACTURE OF MEDICAL DEVICE | IT, ITALY | 84 | DSV SOLUTIONS LLC | INDUSTRIE BORLA S P A |
| SOLAFIT UPGRADE | DE, GERMANY | 13 | SIEMENS MEDICAL SOLUTIONS USA INC | SIEMENS HEALTHINEERS AG |
| PLASTIC PARTS OF HYDROPEEL TIP | CN, CHINA | 351 | EDGE SYSTEMS LLC | TIAN WUN ENGINEERING TRADE CO LIMITED |
| PHARMACEUTICALS HIGH VALUE | DK, DENMARK | 439 | NOVO NORDISK US BIO PRODUCTION | NOVO NORDISK A S |
| DENTAL SUPPLIES | IT, ITALY | 23 | DARBY DENTAL SUPPLY LLC | EURONDA |
